A

AlloCure

50 employees

AlloCure is focused on developing cell therapies for the treatment of various kidney diseases, organ transplants, and multi-organ injuries.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Therapeutics
Medical

Date founded

2008

Funding rounds raised

Total raised

$25M

from 3 investors over 3 rounds

A

AlloCure raised $25M on April 2, 2012

Investors: Lundbeckfonden / Lundbeck Foundation and Novo Holdings

A

AlloCure raised $15M on July 2, 2008

Investors: Novo Holdings

FAQ